In-silico Inhibitory Potential of Triphala Constituents Against Cytochrome P450 2E1 for the Prevention of Thioacetamide-induced Hepatotoxicity

Abstract

Background: Triphala, which is a combination of fruits of Terminalia chebula, Terminalia bellerica and Embilica officinalis generally recommended as herbal drug formulation in the Indian traditional medicine system.
 Study Design: To study the in-silico inhibitory potential of Triphala constituents against cytochrome P450 2E1 (CYP2E1) for the prevention of Thioacetamide-induced Hepatotoxicity
 Place and Duration of Study: The work has been performed at MUP's College of Pharmacy (B Pharm), Degaon, Risod, Washim, Maharashtra, India in between February 2021 to May 2021.
 Methodology: We have studied the inhibitory potential of Triphala on CYP2E1 by applying molecular docking tools. The major chemical constituents of Triphala i.e. gallic acid, chebulic acid, ellagic acid, epicatechin, syringic acid, and ascorbic acid were docked on CYP2E1.
 Results: Docking results revealed the very good inhibitory potential of Triphala in terms of binding affinity towards CYP2E1. All the chemical constituents have formed at least 2 and at most 6 hydrogen bonds with the crystal structure of CYP2E1. The binding energies (kcal/mol) of gallic acid, chebulic acid, ellagic acid, epicatechin, syringic acid, and ascorbic acid are -6.1, -7.1, -9.1, -8.3, -6.3, and -5.7, respectively. Ellagic acid has formed strong hydrogen bonds with Thr-303 and Thr-304 with bond length of 1.98 A0 and 2.26 A0 which confirms the excellent inhibition of CYP2E1.
 Conclusion: These findings can be used to control the CYP2E1-facilitated biotransformation and drug interactions in the development of new chemical entities. In future, these phytoconstituents can be used as lead molecules to overcome the cancer associated with oxidative stress resulting from the hyperactivity of CYP2E1.

Fighting Antibiotic Resistance: New Pyrimidine-Clubbed Benzimidazole Derivatives as Potential DHFR Inhibitors

“…In order to aid molecular docking, a three-dimensional grid box (size_x = 41.7862652138Å; size_y = 39.1754565902Å; size_z = 37.1398050256Å) with an exhaustiveness value of eight was developed [ 34 ]. The strategy reported in previous papers was used in order to carry out the complete molecular docking method as well as to locate cavities and active amino acid residues [ 18 , 28 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 ]. The exposed cavity of the DHFR is shown with the co-crystallized ligand molecule in Figure 4 .…”

Molecular Docking and in vitro Enzyme Assay of Bioactive Compound Isolated from Rhus tripartite Collected from Hail Region of Saudi Arabia as Potential Anti-Diabetic Agent

“…There were active amino acid residues found by using the BIOVIA Discovery Studio Visualizer. The complete molecular docking technique, including identifying cavity and active amino acid residues, was carried out using the strategy described by Khan et al [26][27][28][29][30][31][32][33][34]…”

Pharmacology of Triphala With Special Focus on Their Chemical Constituents

“…The research gave very promising inhibiting efficacy of Triphala in terms of binding affinity towards the chosen target. The study suggested that in future, these molecules can be used to overcome cancer in association with oxidative stress emerging from the abnormally increased activity of CYP2E1 [51].…”